Search - tctmd.com

Displaying 681 - 700 of 1156

Sort: Relevancy | Date

News Daily News

El Cilostazol es Seguro como la Dosis Doble de Clopidogrel en Pacientes sometidos a PCI con un SLF

Yael L. Maxwell

September 20, 2013

News Daily News

DESSOLVE I: SLS de Polímero Bioabsorbible, Prometedor en Lesiones De Novo

Yael L. Maxwell

September 20, 2013

News Daily News

DESSOLVE I: Bioabsorbable Polymer SES Shows Promise in De Novo Lesions

Yael L. Maxwell

September 20, 2013

News Daily News

Cilostazol as Safe as Double-Dose Clopidogrel in Patients Undergoing PCI with DES

Yael L. Maxwell

September 20, 2013

News Conference News ESC 2013

ESC Congress 2013: Mix of Trials with Potential to Reshape Practice

September 09, 2013

News Conference News ESC 2013

Cooling, PCI Improves Long-term Outcomes for Cardiac Arrest Survivors

Yael L. Maxwell

September 04, 2013

News Conference News ESC 2013

CHAMPION: Cangrelor Bests Clopidogrel in PCI Patients in Large Meta-analysis

Yael L. Maxwell

September 03, 2013

News Conference News ESC 2013

TAO: Otamixaban Fails to Outshine Heparin Plus Eptifibatide in NSTE-ACS

Caitlin E. Cox

September 01, 2013

News Conference News ESC 2013

ACCOAST: Prasugrel Pretreatment Increases Bleeding in NSTE-ACS

Yael L. Maxwell

September 01, 2013

News Daily News

El Riesgo Hemorrágico de la Terapia Triple No lo Atenúa la Warfarina Bien Controlada

August 30, 2013

News Daily News

Bleeding Risk of Triple Therapy Not Attenuated by Well-Controlled Warfarin

August 30, 2013

News Daily News

TRILOGY ACS Substudy: Prasugrel Post-Angiography Minimizes Risk of Adverse Events

Yael L. Maxwell

August 23, 2013

News Daily News

Subestudio del TRILOGY ACS: El Prasugrel Post-Angiografía Minimiza el Riesgo de Episodios Adversos

Yael L. Maxwell

August 23, 2013

News Daily News

Upstream Eptifibatide Treatment Linked with Better Outcomes in PCI Patients

Yael L. Maxwell

August 19, 2013

News Daily News

La Administración Upstream de Eptifibatida se asoció a Mejores Resultados en Pacientes PCI

Yael L. Maxwell

August 19, 2013

News Daily News

Un Estudio Analiza las Diferencias en los Resultados PCI en Hospitales Universitarios frente a No Universitarios

Yael L. Maxwell

August 12, 2013

News Daily News

Study Looks at Differences in PCI Outcomes at Teaching vs. Non-Teaching Hospitals

Yael L. Maxwell

August 12, 2013

News Daily News

PLATO: Ticagrelor Lowers Stent Thrombosis vs. Clopidogrel Across the Board in ACS

Caitlin E. Cox

August 12, 2013

News Daily News

PLATO: En Líneas Generales, el Ticagrelor Reduce la Trombosis del Stent frente al Clopidogrel en el Tratamiento del SCA

Caitlin E. Cox

August 12, 2013

News Daily News

No Increased Mortality Risk for DES Patients with High Platelet Reactivity on Clopidogrel

L.A. McKeown

August 12, 2013

Advertisement

El Cilostazol es Seguro como la Dosis Doble de Clopidogrel en Pacientes sometidos a PCI con un SLF

DESSOLVE I: SLS de Polímero Bioabsorbible, Prometedor en Lesiones De Novo

DESSOLVE I: Bioabsorbable Polymer SES Shows Promise in De Novo Lesions

Cilostazol as Safe as Double-Dose Clopidogrel in Patients Undergoing PCI with DES

ESC Congress 2013: Mix of Trials with Potential to Reshape Practice

Cooling, PCI Improves Long-term Outcomes for Cardiac Arrest Survivors

CHAMPION: Cangrelor Bests Clopidogrel in PCI Patients in Large Meta-analysis

TAO: Otamixaban Fails to Outshine Heparin Plus Eptifibatide in NSTE-ACS

ACCOAST: Prasugrel Pretreatment Increases Bleeding in NSTE-ACS

El Riesgo Hemorrágico de la Terapia Triple No lo Atenúa la Warfarina Bien Controlada

Bleeding Risk of Triple Therapy Not Attenuated by Well-Controlled Warfarin

TRILOGY ACS Substudy: Prasugrel Post-Angiography Minimizes Risk of Adverse Events

Subestudio del TRILOGY ACS: El Prasugrel Post-Angiografía Minimiza el Riesgo de Episodios Adversos

Upstream Eptifibatide Treatment Linked with Better Outcomes in PCI Patients

La Administración Upstream de Eptifibatida se asoció a Mejores Resultados en Pacientes PCI

Un Estudio Analiza las Diferencias en los Resultados PCI en Hospitales Universitarios frente a No Universitarios

Study Looks at Differences in PCI Outcomes at Teaching vs. Non-Teaching Hospitals

PLATO: Ticagrelor Lowers Stent Thrombosis vs. Clopidogrel Across the Board in ACS

PLATO: En Líneas Generales, el Ticagrelor Reduce la Trombosis del Stent frente al Clopidogrel en el Tratamiento del SCA

No Increased Mortality Risk for DES Patients with High Platelet Reactivity on Clopidogrel

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content